<DOC>
	<DOCNO>NCT02492386</DOCNO>
	<brief_summary>In prospective , unblinded , single-arm , single-center study , investigator would like assess feasibility safety bioabsorbable everolimus-eluting stent patient erectile dysfunction concomitant internal pudendal artery stenoses . A total 15 bioabsorbable vascular scaffold ( BVSs ) plan assess deploy internal pudendal artery , 1:1 ratio proximal distal segment .</brief_summary>
	<brief_title>Bioabsorbable Everolimus-Eluting Stents Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction</brief_title>
	<detailed_description>Background : Obstructive pelvic arterial lesion present approximately 70-80 % patient age &gt; 50 year erectile dysfunction . Previous study show arterial stenosis present internal pudendal common penile artery segment . Investigators also demonstrate angioplasty internal pudendal penile artery safe achieve clinically significant improvement erectile function ~60 % patient erectile dysfunction . Nevertheless , ZEN study investigator ' preliminary observation , 6-month angiographic binary restenosis rate drug-eluting stent ( DES ) internal pudendal artery approach 30-50 % . The internal pudendal artery require integral vasomotor function provide sufficient blood supply erection , whereas metallic stent impair vasomotor function . A fully bioabsorbable drug-eluting stent scaffold vessel wall need disappear acute recoil constrictive remodeling process subside therefore particularly advantageous internal pudendal artery . Investigators herein would like assess feasibility safety bioabsorbable everolimus-eluting stent patient erectile dysfunction concomitant internal pudendal artery stenosis . Methods : This prospective , unblinded , single-arm , single-center study feasibility trial design provide preliminary observation generate hypothesis future study . A total 15 BVSs plan assess deploy internal pudendal artery , 1:1 ratio proximal distal segment . All subject undergo pelvic CT angiography baseline 6 month intervention . Invasive selective pudendal angiography perform 6-9 month intervention well . Intravascular ultrasound and/or optical coherence tomography ( OCT ) imaging obtain invasive angiography . The primary feasibility endpoint CT angiographic binary restenosis ( ≥50 % lumen diameter stenosis ) 6 month .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Impotence , Vasculogenic</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>men 20 year age old `` consistent '' erectile dysfunction define IIEF5 score , take least 4 week apart , range 5 21 point difference ≤2 point ; anatomical inclusion criterion , base pelvic CT angiography , unilateral luminal diameter stenosis ≥70 % bilateral diameter stenosis ≥50 % internal pudendal artery reference vessel diameter ≥2.5 mm ≤4.0 mm targetlesion length ≤30 mm . arterial inflow penis entirely accessory pudendal artery rather usual internal pudendal artery common penile artery ; presence focal diameter stenosis ≥70 % common penile artery , internal iliac artery , anterior division inferior gluteal artery ; previous radical prostatectomy , pelvic radiation , Peyronie 's disease ; untreated hypogonadism ( serum total testosterone &lt; 300 ng/dL within 14 day enrollment ) ; acute coronary syndrome , stroke , lifethreatening arrhythmia within 3 month enrollment ; poorly control diabetes mellitus glycosylated hemoglobin level &gt; 9 % ; serum creatinine level &gt; 2.5 mg/dL ; bleed diathesis know hypercoagulopathy ; life expectancy few 12 month ; know intolerance contrast agent .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>bioabsorbable vascular scaffold</keyword>
	<keyword>erectile dysfunction</keyword>
</DOC>